We come to the negotiating table with serious firepower. Our team typically works on 100+ transactions in the tech and life sciences sectors every year, including dozens of strategic partnering deals. We’ve done every type of deal that emerging and maturing companies undertake as they develop, acquire and monetize technologies and create new business models to bring products to market.
Emerging companies focus. While other firms focus on working for companies like Google, Cisco, Chevron and GSK, we formed Gunderson Dettmer to work with emerging companies. We can offer you the business knowledge and sophistication normally found only in large law departments at major companies. In essence, we serve as part of your management team and as “outside in-house” counsel. We provide insights and practical experience not otherwise available to emerging companies and sophisticated perspectives for maturing ones.
Business Alignment. We know the structures and strategies that produce win-win deals. With our singular focus and deep experience, we know better than any other firm how to help you create the leverage you need to successfully negotiate strategic deals with much bigger companies. In fact, we wrote the leading book on the subject: Corporate Partnering: Structuring and Negotiating Domestic and International Strategic Alliances (Villeneuve, et al. 2013 Wolters Kluwer), which has been in print continuously since 1992 and is now in its fifth edition.
Practical approach. We use our depth of experience to help you identify and navigate the changing risks and opportunities that come with rapid growth through the lifecycle of your business. Because we’ve advised thousands of emerging companies in commercial deals and acquisitions, we are uniquely able to identify these obstacles and find the best ways to eliminate or navigate them at every stage.
"Gunderson's relationships with VCs/investors who are on the board is a huge benefit. They don't just have a seat at the table—their judgment, knowledge and relationships make life for a founder or a GC much easier."
Veeva Systems, a leader in cloud-based software for global life sciences, has partnered with GD from its start through IPO. “I have high expectations for responsiveness and work quality,” says Josh Faddis, VP & GC. “Everyone at Gunderson has shown total support from our start through IPO and now in our board, strategic, and tech matters: No weak links.”